Latest Options News

Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.

KALINA Power has significantly expanded its land holdings in Alberta, boosting its potential Power-CCS capacity to 1.7 GW to meet surging demand for data centre power solutions with carbon capture.

Eskan Company has received conditional approval for C$13.5 million in funding from Canada’s Critical Minerals Infrastructure Fund to advance the Trans-Atikh Project, a key infrastructure initiative supporting lithium development in Quebec’s Eeyou Istchee James Bay region.

WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.

Advance Metals has secured $1.52 million to fund diamond drilling at its Myrtleford Project in Victoria and confirmatory drilling at its Yoquivo Silver Project in Mexico, with drilling commencing immediately.

Mt Malcolm Mines NL has completed bulk sampling at its Golden Crown Prospect, recovering 218 ounces of gold doré from high-grade material and generating over AUD$835,000 in revenue. The company is now advancing resource estimations and planning future mining strategies.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

WAM Global Limited has announced a special fully franked dividend of AUD 0.04 per share, reflecting strong profitability for the half-year ending December 2024. The dividend will be paid on July 31, 2025, with a Dividend Reinvestment Plan available to shareholders.

The Star Entertainment Group has declined non-binding offers from Chow Tai Fook Enterprises and Far East Consortium for its 50% stake in the Destination Brisbane Joint Venture, citing insufficient value. The company continues to explore liquidity options but faces ongoing uncertainty about its financial stability.

Scentre Group has announced an estimated ordinary dividend of AUD 0.086 per security, payable in late February 2025, signaling steady returns ahead of its full-year financial results.

DEXUS Convenience Retail REIT has announced a final distribution of AUD 0.05138 per security for the quarter ending December 2024, confirming steady income for investors ahead of the February payment date.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.